Erschienen in:
17.06.2016 | Original Paper
Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure
verfasst von:
Shiro Ishihara, Etienne Gayat, Naoki Sato, Mattia Arrigo, Said Laribi, Matthieu Legrand, Rui Placido, Philippe Manivet, Alain Cohen-Solal, William T. Abraham, Mariell Jessup, Alexandre Mebazaa
Erschienen in:
Clinical Research in Cardiology
|
Ausgabe 12/2016
Einloggen, um Zugang zu erhalten
Abstract
Background
Acute heart failure (AHF) with reduced left-ventricular ejection fraction (LVEF) is often a biventricular congested state. The comparative effect of vasodilators and inotropes on the right- and/or left-sided congestion is unknown.
Methods and results
A systematic review, meta-analysis, and meta-regression of AHF studies using pulmonary artery catheter were performed using PubMed, Embase, and Cochrane library. Data from 35 studies, including 3016 patients, were studied. Included patients had a weighted mean age of 60 years, left-ventricular ejection fraction (LVEF) of 24 %, and plasma B-type natriuretic peptide (BNP) of 892 pg/ml. Both the left- and right-ventricular filling pressures were elevated: weighted mean pulmonary artery wedge pressure (PAWP) was 25 mmHg (range 17–31 mmHg) and right atrial pressure (RAP) 12 mmHg (range 7–18 mmHg). Vasodilators and inotropes had similar beneficial effects on PAWP [−6.3 mmHg (95 % CI −7.4 to −5.2 mmHg) and −5.8 mmHg (95 % CI −7.6 to −4.0 mmHg), respectively] and RAP [−2.9 mmHg (95 % CI −3.8 to −2.1 mmHg) and −2.8 mmHg (95 % CI −3.8 to −1.7 mmHg), respectively]. Among inotropes, inodilators, such as levosimendan, have greater beneficial effect on the left-ventricular filling pressure than dobutamine. Drug-induced improvement of PAWP tightly paralleled that of RAP with all studied drugs (r
2 = 0.90, p < 0.001). Vasodilators and inotropes had no short-term effect of renal function.
Conclusion
The left- and right-sided filling pressures are similarly improved by vasodilators or inotropes, in AHF with reduced LVEF.